Wang H, Chai K,Du M, Wang S, et al. Prevalence and incidence of heart failure among urban patients in China: A National Population-based analysis. Circ Heart Fail. 2021;14(10):e008406. https://doi.org/10.1161/circheartfailure.121.008406.
Google Scholar
Wei S, Miranda JJ,Mamas MA,Zühlke LJ,Kontopantelis E,Thabane L, et al. Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019. Eur Heart J Qual Care Clin Outcomes. 2023;9(7):662–72. https://doi.org/10.1093/ehjqcco/qcac088.
Google Scholar
Lawson C, Crothers H, Remsing S, Squire I,Zaccardi F,Davies M, et al. Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity. EClinicalMedicine. 2021;38:101008. https://doi.org/10.1016/j.eclinm.2021.101008.
Google Scholar
Groenewegen A, Rutten FH,Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342–56. https://doi.org/10.1002/ejhf.1858.
Google Scholar
Burnier M, Polychronopoulou E, Wuerzner G. Hypertension and drug adherence in the Elderly. Front Cardiovasc Med. 2020;7:49. https://doi.org/10.3389/fcvm.2020.00049.
Google Scholar
Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294(4):466–72. https://doi.org/10.1001/jama.294.4.466.
Google Scholar
Connelly PJ, Currie G, Delles C. Sex differences in the prevalence, outcomes and management of hypertension. Curr Hypertens Rep. 2022;24(6):185–92. https://doi.org/10.1007/s11906-022-01183-8.
Google Scholar
Virani SS, Alonso A, Benjamin EJ,Bittencourt MS,Callaway CW,Carson AP, et al. Heart Disease and Stroke Statistics-2020 update: a Report from the American Heart Association. Circulation. 2020;141(9):e139–596. https://doi.org/10.1161/cir.0000000000000757.
Google Scholar
Egan BM, Mattix-Kramer HJ, Basile JN, Sutherland SE. Managing hypertension in older adults. Curr Hypertens Rep. 2024;26(4):157–67. https://doi.org/10.1007/s11906-023-01289-7.
Google Scholar
Ji H, Kim A, Ebinger JE,Niiranen TJ, Claggett BL, Bairey Merz CN, et al. Sex differences in blood pressure trajectories over the life course. JAMA Cardiol. 2020;5(3):19–26. https://doi.org/10.1001/jamacardio.2019.5306.
Google Scholar
Franklin SS, Jacobs MJ, Wong ND,L’italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001;37(3):869–74. https://doi.org/10.1161/01.hyp.37.3.869.
Google Scholar
Paneni F, Diaz Cañestro C,Libby P,Lüscher TF, Camici GG. The aging cardiovascular system: understanding it at the cellular and clinical levels. J Am Coll Cardiol, 2017;69(15): 1952–1967.https://doi.org/10.1016/j.jacc.2017.01.064
Conrad N, Judge A, Tran J, Mohseni H,Hedgecott D, Crespillo AP, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572–80. https://doi.org/10.1016/s0140-6736(17)32520-5.
Google Scholar
Rapsomaniki E, Timmis A, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383(9932):1899–911. https://doi.org/10.1016/s0140-6736(14)60685-1.
Google Scholar
Benetos A, Bulpitt CJ,Petrovic M, Ungar A, Agabiti Rosei E, Cherubini A, et al. An expert opinion from the european society of hypertension-european union geriatric medicine society working group on the management of hypertension in very old. Frail Subj Hypertens. 2016;67(5):820–5. https://doi.org/10.1161/hypertensionaha.115.07020.
Google Scholar
Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(1):30–41. https://doi.org/10.1038/nrcardio.2010.165.
Google Scholar
Echeverria LE, Martinez E, Gomez-Mesa J, Rivera-Toquica A. Zarama M,Ramírez EG,et al. J Card Fail. 2023;29(4):637–8. Clinical Characteristics And Outcomes Of Patients With Heart Failure Of Hypertensive Etiology: Analysis Of The Colombian Registry Of Heart Failure [J].
Aguilar D. Preventing heart failure in people with hypertension: the time is now [J]. JACC Heart Fail. 2023;11(6):689–90. https://doi.org/10.1016/j.jchf.2023.04.004.
Google Scholar
Arroyo JCT, Delima AJP. An optimized neural network using genetic Algorithm for Cardiovascular Disease prediction. Journal of Advances in Information Technology; 2022.
Lin CM, Lin YS. Utilizing a two-stage Taguchi Method and Artificial neural network for the precise forecasting of Cardiovascular Disease risk [J]. Bioeng (Basel). 2023;10(11). https://doi.org/10.3390/bioengineering10111286.
Lin C-M, Lin Y-S, TPTM-HANN-GA:. A Novel Hyperparameter Optimization Framework Integrating the Taguchi Method, an Artificial Neural Network, and a Genetic Algorithm for the Precise Prediction of Cardiovascular Disease Risk [J]. Mathematics, 2024.
Sadr H, Salari A, Ashoobi MT, Nazari M. Cardiovascular disease diagnosis: a holistic approach using the integration of machine learning and deep learning models [J]. Eur J Med Res. 2024;29(1):455. https://doi.org/10.1186/s40001-024-02044-7.
Google Scholar
Tohyama T, Ide T, Ikeda M,Kaku H, Enzan N,Matsushima S, et al. Machine learning-based model for predicting 1 year mortality of hospitalized patients with heart failure [J]. ESC Heart Fail. 2021;8(5):4077–85. https://doi.org/10.1002/ehf2.13556.
Google Scholar
Li F, Xin H, Zhang J, Lian Z. Prediction model of in-hospital mortality in intensive care unit patients with heart failure: machine learning-based, retrospective analysis of the MIMIC-III database [J]. BMJ Open. 2021;11(7):e044779. https://doi.org/10.1136/bmjopen-2020-044779.
Google Scholar
Dharmarathne G, Bogahawaththa M, Mcafee M, Rathnayake US, Meddage DPP. On the diagnosis of chronic kidney disease using a machine learning-based interface with explainable artificial intelligence [J]. Intell Syst Appl. 2024;22:200397.
Dharmarathne G, Bogahawaththa M, Rathnayake US, Meddage DPP. Integrating explainable machine learning and user-centric model for diagnosing cardiovascular disease: a novel approach [J]. Intell Syst Appl. 2024;23:200428.
Dharmarathne G, Jayasinghe TN, Bogahawaththa M, Meddage DP, Rathnayake U. A novel machine learning approach for diagnosing diabetes with a self-explainable interface. Healthcare Anal. 2024;5:100301.
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement [J]. BMJ. 2015;350:g7594. https://doi.org/10.1136/bmj.g7594.
Google Scholar
Vasques AC, Novaes FS, De Oliveira Mda S, Souza JR, Yamanaka A,Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study [J]. Diabetes Res Clin Pract. 2011;93(3):e98–100. https://doi.org/10.1016/j.diabres.2011.05.030.
Google Scholar
Chao P, Cui X,Wang S, Zhang L, Ma Q, Zhang X. Serum albumin and the short-term mortality in individuals with congestive heart failure in intensive care unit: an analysis of MIMIC [J]. Sci Rep. 2022;12(1):16251. https://doi.org/10.1038/s41598-022-20600-1.
Google Scholar
Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001–2018 [J]. Cardiovasc Diabetol. 2023;22(1):279. https://doi.org/10.1186/s12933-023-02030-z.
Google Scholar
Wen J, Pan Q, Du LL,Song JJ, Liu YP, Meng XB, et al. Association of triglyceride-glucose index with atherosclerotic cardiovascular disease and mortality among familial hypercholesterolemia patients [J]. Diabetol Metab Syndr. 2023;15(1):39. https://doi.org/10.1186/s13098-023-01009-w.
Google Scholar
Zhou Y, Wang CCH, Zhu D,Rao C, et al. Association between the triglyceride-glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China [J]. Cardiovasc Diabetol. 2023;22(1):171. https://doi.org/10.1186/s12933-023-01895-4.
Google Scholar
Liao Y, Zhang R, Shi S,Zhao Y, He Y,Liao L, et al. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients [J]. Cardiovasc Diabetol. 2022;21(1):128. https://doi.org/10.1186/s12933-022-01563-z.
Google Scholar
Jia Y, Zhang Y, Bai S,Liu J, Chen T, Liu X, et al. Triglyceride glucose index is a risk factor for heart failure: a prospective cohort study [J]. ESC Heart Fail. 2024. https://doi.org/10.1002/ehf2.14963.
Google Scholar
Özcan, KS,Hayıroğlu MI, Çınar T. Admission triglyceride-glucose index is predictor of long-term mortality and appropriate implantable cardiac defibrillator therapy in patients with heart failure [J]. Biomark Med. 2023;17(10):487–96. https://doi.org/10.2217/bmm-2023-0113.
Li X, Wang JNL, Tan Z,Ma J, He L, et al. Prevalence estimates of the insulin resistance and associated prevalence of heart failure among United Status adults [J]. BMC Cardiovasc Disord. 2023;23(1):294. https://doi.org/10.1186/s12872-023-03294-9.
Google Scholar
Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, et al. Missing value estimation methods for DNA microarrays [J]. Bioinformatics. 2001;17(6):520–5. https://doi.org/10.1093/bioinformatics/17.6.520.
Google Scholar
Gromski PS, Xu Y, Kotze HL,Correa E, Ellis DI, Armitage EG, et al. Influence of missing values substitutes on multivariate analysis of metabolomics data [J]. Metabolites. 2014;4(2):433–52. https://doi.org/10.3390/metabo4020433.
Google Scholar
Liu XZ, Duan M, Huang HD, Zhang Y, Xiang TY,Niu WC, et al. Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study [J]. Front Endocrinol (Lausanne). 2023;14:1184190. https://doi.org/10.3389/fendo.2023.1184190.
Google Scholar
Wang K, Tian J, Zheng C,Yang H,Ren J, Li C, et al. Improving risk identification of adverse outcomes in Chronic Heart failure using SMOTE + ENN and Machine Learning [J]. Risk Manag Healthc Policy. 2021;14:2453–63. https://doi.org/10.2147/rmhp.S310295.
Google Scholar
Angraal S, Mortazavi BJ, Gupta A,Khera R, Ahmad T,Desai NR, et al. Machine learning prediction of mortality and hospitalization in heart failure with preserved ejection fraction [J]. JACC Heart Fail. 2020;8(1):12–21. https://doi.org/10.1016/j.jchf.2019.06.013.
Google Scholar
Lundberg SM, Erion G, Chen H, Degrave A,Prutkin JM, Nair B, et al. From local explanations to Global understanding with explainable AI for trees [J]. Nat Mach Intell. 2020;2(1):56–67. https://doi.org/10.1038/s42256-019-0138-9.
Google Scholar
Nohara Y, Matsumoto K, Soejima H, Nakashima N. Explanation of machine learning models using shapley additive explanation and application for real data in hospital [J]. Comput Methods Programs Biomed. 2022;214:106584. https://doi.org/10.1016/j.cmpb.2021.106584.
Google Scholar
Hu C, Li L, Huang W, Wu T, et al. Interpretable Machine Learning for early prediction of prognosis in Sepsis: A Discovery and Validation Study [J]. Infect Dis Ther. 2022;11(3):1117–32. https://doi.org/10.1007/s40121-022-00628-6.
Google Scholar
Miao H, Zou C, Yang S, Chia YC, Van Huynh M, Sogunuru GP, et al. Targets and management of hypertension in heart failure: focusing on the stages of heart failure [J]. J Clin Hypertens (Greenwich). 2022;24(9):1218–25. https://doi.org/10.1111/jch.14553.
Google Scholar
Maio R, Perticone M, Suraci E, Sciacqua A,Sesti G, Perticone F. Endothelial dysfunction and C-reactive protein predict the incidence of heart failure in hypertensive patients [J]. ESC Heart Fail. 2021;8(1):399–407. https://doi.org/10.1002/ehf2.13088.
Google Scholar
Fernandez C, Rysä J,Ström K,Nilsson JEngströmG, Orho-Melander M, et al. Circulating protein biomarkers predict incident hypertensive heart failure independently of N-terminal pro-B-type natriuretic peptide levels [J]. ESC Heart Fail. 2020;7(4):1891–9. https://doi.org/10.1002/ehf2.12757.
Google Scholar
Li J, Liu S, Hu Y,Zhu L,Mao Y, Liu J. Predicting Mortality in Intensive Care Unit patients with heart failure using an interpretable machine learning model: retrospective cohort study [J]. J Med Internet Res. 2022;24(8):e38082. https://doi.org/10.2196/38082.
Google Scholar
Peng S, Huang J, Liu X,Deng J, Sun C,Tang J, et al. Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: a retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases [J]. Front Cardiovasc Med. 2022;9:994359. https://doi.org/10.3389/fcvm.2022.994359.
Google Scholar
Sabouri M, Rajabi AB, Hajianfar G, Gharibi O,Mohebi M, Avval AH, et al. Machine learning based readmission and mortality prediction in heart failure patients [J]. Sci Rep. 2023;13(1):18671. https://doi.org/10.1038/s41598-023-45925-3.
Google Scholar
Voors AA, Ouwerkerk W, Zannad F, Van Veldhuisen DJ, Samani NJ, Ponikowski P, et al. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure [J]. Eur J Heart Fail. 2017;19(5):627–34. https://doi.org/10.1002/ejhf.785.
Google Scholar
Ouwerkerk W, Voors AA, Zwinderman AH. Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure [J]. JACC Heart Fail. 2014;2(5):429–36. https://doi.org/10.1016/j.jchf.2014.04.006.
Google Scholar
Pocock SJ, Ariti CA, Mcmurray JJ, Maggioni A,Køber L,Squire IB, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies [J]. Eur Heart J. 2013;34(19):1404–13. https://doi.org/10.1093/eurheartj/ehs337.
Google Scholar
Reynolds K, Butler MG,Kimes TM,Rosales AG, Chan W, Nichols GA. Relation of Acute Heart failure hospital length of stay to subsequent readmission and all-cause mortality [J]. Am J Cardiol. 2015;116(3):400–5. https://doi.org/10.1016/j.amjcard.2015.04.052.
Google Scholar
Ancion A, Allepaerts S, Oury C, Gori AS,Piérard LA, Lancellotti P. Serum albumin level and hospital mortality in acute non-ischemic heart failure [J]. ESC Heart Fail. 2017;4(2):138–45. https://doi.org/10.1002/ehf2.12128.
Google Scholar
Rana JS, Boekholdt SM,Ridker PM, Jukema JW,Luben R, Bingham SA, et al. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk prospective Population study [J]. J Intern Med. 2007;262(6):678–89. https://doi.org/10.1111/j.1365-2796.2007.01864.x.
Google Scholar
Tang X, Wang P, Vinayachandran V, et al. KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression [J]. J Clin Invest. 2022. https://doi.org/10.1172/jci147191.
Metra M, Cotter G, El-Khorazaty J, Davison BA, Milo O,Carubelli V, et al. Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS study [J]. J Card Fail. 2015;21(3):179–88. https://doi.org/10.1016/j.cardfail.2014.12.012.
Google Scholar
Gotsman I, Shauer A, Zwas DR,Tahiroglu I,Lotan C, Keren A. Low serum albumin: a significant predictor of reduced survival in patients with chronic heart failure [J]. Clin Cardiol. 2019;42(3):365–72. https://doi.org/10.1002/clc.23153.
Google Scholar
Li X, Chan JSK,Guan BPSWX, Lu X, et al. Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a mendelian randomization analysis [J]. Cardiovasc Diabetol. 2022;21(1):229. https://doi.org/10.1186/s12933-022-01658-7.
Google Scholar
Zheng H, Chen G, Wu KWWHZ, Wang X, et al. Relationship between cumulative exposure to triglyceride-glucose index and heart failure: a prospective cohort study [J]. Cardiovasc Diabetol. 2023;22(1):239. https://doi.org/10.1186/s12933-023-01967-5.
Google Scholar
Khalaji A, Behnoush AH, Khanmohammadi S, Ghanbari Mardasi K, Sharifkashani S, Sahebkar A, et al. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis [J]. Cardiovasc Diabetol. 2023;22(1):244. https://doi.org/10.1186/s12933-023-01973-7.
Google Scholar
Tao LC, Xu JN, Wang TT,Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations [J]. Cardiovasc Diabetol. 2022;21(1):68. https://doi.org/10.1186/s12933-022-01511-x.
Google Scholar
Araújo SP, Juvanhol LL, Bressan J, Hermsdorff HHM. Triglyceride glucose index: a new biomarker in predicting cardiovascular risk [J]. Prev Med Rep. 2022;29:101941doi. https://doi.org/10.1016/j.pmedr.2022.101941.
Google Scholar
Adams KF, Jr.,Fonarow GC, Emerman CL,Lejemtel TH,Costanzo MR, Abraham WT et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J]. Am Heart J, 2005, 149(2): 209–216.https://doi.org/10.1016/j.ahj.2004.08.005
Chioncel O, Ambrosy AP,Filipescu D, Bubenek S, Vinereanu D,Petris A, et al. Patterns of intensive care unit admissions in patients hospitalized for heart failure: insights from the RO-AHFS registry [J]. J Cardiovasc Med (Hagerstown). 2015;16(5):331–40. https://doi.org/10.2459/jcm.0000000000000030.
Google Scholar
link